Cascades Inc. (TSE:CAS – Get Free Report) shares dropped 3.9% during trading on Thursday . The company traded as low as C$12.21 and last traded at C$12.30. Approximately 91,738 shares were traded during trading, a decline of 60% from the average daily volume of 226,883 shares. The stock had previously closed at C$12.80.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the stock. TD Securities increased their target price on shares of Cascades from C$12.00 to C$14.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Scotiabank raised Cascades from a “hold” rating to a “strong-buy” rating and increased their price target for the company from C$12.00 to C$15.50 in a research note on Monday, January 27th. Royal Bank of Canada lifted their price target on Cascades from C$12.00 to C$13.00 and gave the company a “sector perform” rating in a research report on Friday, December 20th. Finally, CIBC upped their price objective on Cascades from C$12.00 to C$13.00 in a report on Wednesday, January 15th. Four analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Cascades has an average rating of “Moderate Buy” and a consensus target price of C$13.25.
Check Out Our Latest Stock Analysis on CAS
Cascades Stock Down 6.3 %
About Cascades
Cascades Inc produces, converts, and markets packaging and tissue products in Canada and the United States. The company operates through three segments: Containerboard, Specialty Products, and Tissue Papers. It offers various packaging solutions and tissue products comprised of recycled fibers; tissue papers, comprising parent rolls of virgin and recycled fibres; specialty products, including uncoated recycled boxboards; and containerboards.
Featured Articles
- Five stocks we like better than Cascades
- 3 Warren Buffett Stocks to Buy Now
- Tesla: 2 Reasons to Buy, 1 Reason to Run
- 3 REITs to Buy and Hold for the Long Term
- Should You Hold NVIDIA Stock for the Long Haul or Trade It?
- The How and Why of Investing in Gold Stocks
- Humana Gains Despite Medicare Advantage Losses—What’s the Catch?
Receive News & Ratings for Cascades Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cascades and related companies with MarketBeat.com's FREE daily email newsletter.